In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment

Regulatory Peptides

Volumn 184, Issue , 2013, Pages 81-84

  Neve, Anna ^a   Cantatore, Francesco Paolo ^a   Corrado, Addolorata ^a   Gaudio, Annamaria ^a   Ruggieri, Simona ^b   Ribatti, Domenico ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Angiogenesis; Chorioallantoic membrane; Osteoarthritis; Osteoporosis; Vitamin D3

Indexed keywords

CALCITRIOL; MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CHICK EMBRYO; CHORIOALLANTOIS; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOARTHRITIS; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; VASCULOTROPIN GENE;

ADULT; AGED; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CELLS, CULTURED; CHICK EMBRYO; CHOLECALCIFEROL; CHORIOALLANTOIC MEMBRANE; CULTURE MEDIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOARTHRITIS; OSTEOBLASTS; OSTEOPOROSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITAMINS;

EID: 84876400388     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.03.014     Document Type: Article

References (36)

1. Colnot C., Lu C., Hu D., Helms J.A. Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev Biol 2004, 269:55-69.
2. Hausman M.R., Schaffler M.B., Majeska R.J. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001, 29:560-564.
3. Ribatti D., Nico B., Vacca A., Presta M. The gelatin sponge-chorioallantoic membrane assay. Nat Protoc 2006, 1:85-91.
4. Grellier M., Granja P.L., Fricain J.C., Bidarra S.J., Renard M., Bareille R., Bourget C., Amédée J., Barbosa M.A. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 2009, 30:3271-3278.
5. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
6. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 2001, 276:7614-7620.
7. Karsan A., Yee E., Poirier G.G., Zhou P., Craig R., Harlan J.M. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 1997, 151:1775-1784.
8. Thommen R., Humar R., Misevic G., Pepper M.S., Hahn A.W., John M., Battegay E.J. PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro. J Cell Biochem 1997, 64:403-413.
9. Ribatti D. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. Br J Haematol 2005, 128:303-309.
10. Midy V., Plouët J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 1994, 199:380-386.
11. Mayr-Wohlfart U., Waltenberger J., Hausser H., Kessler S., Günther K.P., Dehio C., Puhl W., Brenner R.E. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002, 30:472-477.
12. Tan Y.Y., Yang Y.Q., Chai L., Wong R.W., Rabie A.B. Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. Orthod Craniofac Res 2010, 13:223-228.
13. Mayer H., Bertram H., Lindenmaier W., Korff T., Weber H., Weich H. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 2005, 95:827-839.
14. Street J., Lenehan B. Vascular endothelial growth factor regulates osteoblast survival-evidence for an autocrine feedback mechanism. J Orthop Surg Res 2009, 16:4-19.
15. Corrado A., Neve A., Maruotti N., Gaudio A., Marucci A., Cantatore F.P. Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. Clin Exp Rheumatol 2010, 28:873-879.
16. Wang D.S., Yamazaki K., Nohtomi K., Shizume K., Ohsumi K., Shibuya M., Demura H., Sato K. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 1996, 11:472-479.
17. T method. Nat Protoc 2008, 3:1101-1108.
18. Ribatti D. Genetic and epigenetic mechanisms in the early development of the vascular system. J Anat 2006, 208:139-152.
19. Haller A. Experimentorum de ossiem formatione. Opera minora 1763, 400. Francisci Grasset, Lausanne.
20. Wang Y., Wan C., Deng L., Liu X., Cao X., Gilbert S.R., Bouxsein M.L., Faugere M.C., Guldberg R.E., Gerstenfeld L.C., Haase V.H., Johnson R.S., Schipani E., Clemens T.L. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007, 117:1616-1626.
21. Saadeh P., Mehrara B., Steinbrech D., Dudziak M., Gosain A., Gittes G., Longaker M. Transforming growth factor-β1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Physiol Cell Physiol 1999, 277:C628-C637.
22. Spector J.A., Mehrara B.J., Greenwald J.A., Saadeh P.B., Steinbrech D.S., Bouletreau P.J., Smith L.P., Longaker M.T. Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular microenvironment. Am J Physiol Cell Physiol 2001, 280:C72-C80.
23. Akeno N., Czyzyk-Krzeska M.F., Gross T.S., Clemens T.L. Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2alpha. Endocrinology 2001, 142:959-962.
24. Deckers M.M., Karperien M., Bent C., Yamashita T., Papapoulos S.E., Lowik C.W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000, 141:1667-1674.
25. Corrado A., Neve A., Cantatore F.P. Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. Clin Exp Med Nov. 29 2011, [Epub ahead of print].
26. Ribatti D. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Int Rev Cell Mol Biol 2008, 270(181):224.
27. Radin E.L., Rose R.M. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 1986, 213:34.
28. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 1998, 6:1306-1309. [374-76.246, 1989].
29. Cebi H., Akşahin E., Yüksel H.Y., Celebi L., Aktekin C.N., Hapa O., Muratli H.H., Biçimoǧlu A. Plasma vascular endothelial growth factor levels are similar in subjects with and without osteoporosis. Eklem Hastalik Cerrahisi 2010, 21:91-97.
30. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
31. Motro B., Itin A., Sachs L., Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A 1990, 87:3092-3096.
32. Cantatore F.P., Crivellato E., Nico B., Ribatti D. Osteocalcin is angiogenic in vivo. Cell Biol Int 2005, 29:583-585.
33. Leali D., Dell'Era P., Stabile H., Sennino B., Chambers A.F., Naldini A., Sozzani S., Nico B., Ribatti D., Presta M. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J Immunol 2003, 171:1085-1093.
34. Nicosia R.F., Nicosia S.V., Smith M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 1994, 145:1023-1029.
35. Weinstein R.S., Wan C., Liu Q., Wang Y., Almeida M., O'Brien C.A., Thostenson J., Roberson P.K., Boskey A.L., Clemens T.L., Manolagas S.C. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 2010, 9:147-161.
36. Zhao Q., Shen X., Zhang W., Zhu G., Qi J., Deng L. Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss. Bone 2012, 50:763-770.